- Home
- NWBI vs BHVN Comparison
NWBI vs BHVN Comparison
Compare NWBI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWBI | BHVN |
|---|---|---|
| Founded | 1896 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2009 | 2022 |
Fundamental Metrics
Financial Performance| Metric | NWBI | BHVN |
|---|---|---|
| Price | $15.55 | $15.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | $14.50 | ★ $29.08 |
| AVG Volume (30 Days) | 1.3M | ★ 3.6M |
| Earning Date | 04-27-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.82% | N/A |
| EPS Growth | 16.46 | ★ 26.08 |
| EPS | ★ 0.34 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.29 | N/A |
| Revenue Next Year | $5.06 | N/A |
| P/E Ratio | $46.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.25 | $7.48 |
| 52 Week High | $15.72 | $18.57 |
Technical Indicators
Market Signals| Indicator | NWBI | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 66.54 | 57.56 |
| Support Level | $11.81 | $14.44 |
| Resistance Level | N/A | $17.01 |
| Average True Range (ATR) | 0.25 | 1.01 |
| MACD | 0.02 | -0.28 |
| Stochastic Oscillator | 83.17 | 49.72 |
Price Performance
Historical ComparisonAbout NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.